Brinter develops 3D bioprinted implants for human tissue repair across orthopedic and aesthetic applications. The company utilizes patented 3D BioPrinter technology for scalable, automated mass manufacturing of medical devices. Their implants feature biomimetic architecture and bioactive materials designed to accelerate tissue regeneration and integrate with the patient's body.
Funding
$4.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional surgical implants for soft tissue repair often lack the ability to fully integrate with the body, leading to complications and limited long-term regeneration. Existing solutions may not adequately support the natural healing process, resulting in suboptimal outcomes for patients with conditions like rotator cuff tears.
Solution
Brinter develops 3D bioprinted biocomposite implants, called BioMods™, designed to enhance soft tissue regeneration and address the limitations of conventional implants. These fully resorbable implants are engineered with a biomimetic architecture and bioactive materials to accelerate tissue repair. Brinter's modular 3D bioprinting platform enables the creation of personalized implants tailored to individual patient needs. The BioMods™ support the body’s natural healing cascade, gradually degrading as new, functional tissue forms. Initially focused on rotator cuff repair, Brinter's technology is designed to scale for various surgical applications, including aesthetics and eventually organ bioprinting.
Target Audience
The primary target audience includes orthopedic surgeons specializing in sports medicine and soft tissue repair, as well as hospitals and clinics focused on regenerative medicine.
Features
- 3D bioprinted biocomposite implants (BioMods™) for soft tissue repair
- Bioresorbable materials that support natural tissue regeneration
- Biomimetic architecture designed to mimic and enhance tissue growth
- Modular 3D bioprinting platform for scalable manufacturing
- Capability to create personalized implants tailored to individual needs
- Multi-material printing capabilities using biological and synthetic materials